In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme: Why Diversification is Starting to Look Smart

Executive Summary

As the blockbuster model comes under threat, Genzyme's highly diversified approach begins to look smart. Plenty of larger companies likely envy Genzyme's specialist expertise, tight customer relationships and long-standing embrace of external R&D. It's up to CEO Henri Termeer to prove that these strengths warrant an independent future for Genzyme.
Advertisement

Related Content

Genzyme's Manufacturing Problems
Actelion Follows Innovation into GP Markets
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2008
Genzyme/Isis: Has ENHANCE Dulled Mipomersen's Prospects?
Orphaning Biotech? The Impact of Biosimilars on Biotech Investment
Phase III Prostate Cancer Failures: Taxotere to Blame?
Can Amgen Find a New Engine?
Genzyme Breaks a Biotech Taboo: The Hostile Bid For AnorMED
Novartis Buys into New Pharma World Order
Keeping Track of Genzyme

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel